Non-Hodgkin lymphoma

General news: Approvals: Genzyme's stem cell transplant drug Mozobil; Abbott's triglyceride drug TriLipix; Eisai's Lusedra for anesthesia. Novartis' experimental MS drug (oral) looking really good …

Continue Reading about Pharma News this week →